This complex disease comprises various subtypes, including hormone receptor-positive breast cancer, human epidermal growth factor receptor 2 (HER2)-positive breast cancer, and the notably aggressive triple-negative breast cancer (TNBC) [3, 4]. This evidence concerns the gene ERBB2 and breast cancer.